Production (Stage)
Kura Oncology, Inc.
KURA
$6.73
$0.162.44%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.96% | 55.09% | -40.94% | -36.75% | -45.37% |
| Total Depreciation and Amortization | 2.99% | -4.67% | -3.70% | -5.16% | 13.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.95% | 29.28% | 16.17% | 0.20% | 1.86% |
| Change in Net Operating Assets | -307.81% | 7,505.98% | 13.86% | -51.20% | 32.41% |
| Cash from Operations | -47.26% | 884.46% | -49.65% | -66.02% | -36.16% |
| Capital Expenditure | -247.62% | -2,225.00% | 100.00% | 83.33% | -133.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.16% | -324.07% | 430.77% | 193.41% | -953.14% |
| Cash from Investing | -6.37% | -325.04% | 432.01% | 193.18% | -956.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.90% | 16.64% | 2,521.43% | -96.77% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.90% | 16.64% | 2,521.43% | -96.77% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,235.46% | 1,939.89% | 121.08% | -83.34% | 116.93% |